These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12773449)

  • 1. Dual renin-angiotensin blockade therapy in patients at high risk of early ovarian hyperstimulation syndrome receiving IVF and elective embryo cryopreservation: a case series.
    Ando H; Furugori K; Shibata D; Harata T; Murata Y; Mizutani S
    Hum Reprod; 2003 Jun; 18(6):1219-22. PubMed ID: 12773449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual renin-angiotensin blockage and total embryo cryopreservation is not a risk-free strategy in patients at high risk for ovarian hyperstimulation syndrome.
    Ata B; Yakin K; Alatas C; Urman B
    Fertil Steril; 2008 Sep; 90(3):531-6. PubMed ID: 18001715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuation of GnRH agonist administration for 1 week, after hCG injection, prevents ovarian hyperstimulation syndrome following elective cryopreservation of all pronucleate embryos.
    Endo T; Honnma H; Hayashi T; Chida M; Yamazaki K; Kitajima Y; Azumaguchi A; Kamiya H; Kudo R
    Hum Reprod; 2002 Oct; 17(10):2548-51. PubMed ID: 12351526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.
    Anaya Y; Mata DA; Letourneau J; Cakmak H; Cedars MI; Rosen MP
    J Assist Reprod Genet; 2018 Feb; 35(2):297-307. PubMed ID: 29086322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of intravenous albumin and transfer of fresh embryos with cryopreservation of all embryos for subsequent transfer in prevention of ovarian hyperstimulation syndrome.
    Shaker AG; Zosmer A; Dean N; Bekir JS; Jacobs HS; Tan SL
    Fertil Steril; 1996 May; 65(5):992-6. PubMed ID: 8612863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embryo freezing for preventing Ovarian Hyperstimulation Syndrome.
    D'Angelo A; Amso N
    Cochrane Database Syst Rev; 2002; (2):CD002806. PubMed ID: 12076453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSS.
    Lainas GT; Kolibianakis EM; Sfontouris IA; Zorzovilis IZ; Petsas GK; Lainas TG; Tarlatzis BC
    Hum Reprod; 2013 Jul; 28(7):1929-42. PubMed ID: 23624582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elective cryopreservation of all pronucleate embryos in women at risk of ovarian hyperstimulation syndrome: efficiency and safety.
    Ferraretti AP; Gianaroli L; Magli C; Fortini D; Selman HA; Feliciani E
    Hum Reprod; 1999 Jun; 14(6):1457-60. PubMed ID: 10357958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GnRH antagonist administered twice the day before hCG trigger combined with a step-down protocol may prevent OHSS in IVF/ICSI antagonist cycles at risk for OHSS without affecting the reproductive outcomes: a prospective randomized control trial.
    Prapas Y; Ravanos K; Petousis S; Panagiotidis Y; Papatheodorou A; Margioula-Siarkou C; Iuliano A; Gullo G; Prapas N
    J Assist Reprod Genet; 2017 Nov; 34(11):1537-1545. PubMed ID: 28776117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does elective cryopreservation of all embryos from women at risk of ovarian hyperstimulation syndrome reduce the incidence of the condition?
    Wada I; Matson PL; Troup SA; Morroll DR; Hunt L; Lieberman BA
    Br J Obstet Gynaecol; 1993 Mar; 100(3):265-9. PubMed ID: 8476833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correctly timed coasting reduces the risk of ovarian hyperstimulation syndrome and gives good cycle outcome in an in vitro fertilization program.
    Grochowski D; Wołczyński S; Kuczyński W; Domitrz J; Szamatowicz J; Szamatowicz M
    Gynecol Endocrinol; 2001 Jun; 15(3):234-8. PubMed ID: 11447736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients.
    Humaidan P; Polyzos NP; Alsbjerg B; Erb K; Mikkelsen AL; Elbaek HO; Papanikolaou EG; Andersen CY
    Hum Reprod; 2013 Sep; 28(9):2511-21. PubMed ID: 23753114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of letrozole on moderate and severe early-onset ovarian hyperstimulation syndrome in high-risk women: a prospective randomized trial.
    Mai Q; Hu X; Yang G; Luo Y; Huang K; Yuan Y; Zhou C
    Am J Obstet Gynecol; 2017 Jan; 216(1):42.e1-42.e10. PubMed ID: 27555316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevention of ovarian hyperstimulation syndrome.
    Corbett S; Shmorgun D; Claman P; ;
    J Obstet Gynaecol Can; 2014 Nov; 36(11):1024-1033. PubMed ID: 25574681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome - a prospective randomized double-blind clinical trial.
    Engmann LL; Maslow BS; Kaye LA; Griffin DW; DiLuigi AJ; Schmidt DW; Grow DR; Nulsen JC; Benadiva CA
    J Ovarian Res; 2019 Jan; 12(1):8. PubMed ID: 30684970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian hyperstimulation syndrome prevention strategies: cryopreservation of all embryos.
    D'Angelo A
    Semin Reprod Med; 2010 Nov; 28(6):513-8. PubMed ID: 21082511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does withholding gonadotrophin administration prevent severe ovarian hyperstimulation syndrome?
    Lee C; Tummon I; Martin J; Nisker J; Power S; Tekpetey F
    Hum Reprod; 1998 May; 13(5):1157-8. PubMed ID: 9647538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels.
    Manzanares MA; Gómez-Palomares JL; Ricciarelli E; Hernández ER
    Fertil Steril; 2010 Mar; 93(4):1215-9. PubMed ID: 19200978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG.
    Seyhan A; Ata B; Polat M; Son WY; Yarali H; Dahan MH
    Hum Reprod; 2013 Sep; 28(9):2522-8. PubMed ID: 23633553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elective cryopreservation of all embryos in women at risk of developing ovarian hyperstimulation syndrome may not prevent the condition but reduces the live birth rate.
    Awonuga AO; Pittrof RJ; Zaidi J; Dean N; Jacobs HS; Tan SL
    J Assist Reprod Genet; 1996 May; 13(5):401-6. PubMed ID: 8739056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.